Panel Discussion: Next-gen Pharma Innovation

Panellists in this video:
+ Mr Naresh Gaur, EVP Operations, Stallion Laboratories (Moderator)
+ Dr Vaibhav Dubey, GM, Kashiv Biosciences
+ Mr Yogesh Joshi, Head- Formulation Development CDMO, Head Clinical Manufacturing Operation, Piramal Pharma Solutions
+ Dr Kiran Marthak, Director – Medical Affairs, Phase-1 and Regulatory Affairs, Veeda Lifesciences
+ Mr Hiren Shah, GM – Packaging Development, Cadila Pharmaceuticals
+ Mr Ashwani Verma, Sr GM – Operations, Intas Pharmaceuticals

Key Highlights:
[1] For India Pharma Inc., sustained growth hinges on strategic investments in innovation, including drug discovery and development

[2] Technology transformation is essential: Digitalisation, automation, and AI are transforming pharma operations by enhancing quality, ensuring compliance, and accelerating innovation.

[3] There’s significant room for innovation in biologics, especially in high-burden therapeutic areas like oncology and diabetes, to lower costs and improve outcomes.

[4] Incremental innovation matters. Even small, thoughtful changes can have a big impact—like digitising medical leaflets to cut costs and streamline packaging.

[5] Embracing digital tools helps pharma companies keep pace with increasingly complex and evolving global regulatory standards.

[6] Innovations that enhance accessibility, affordability, and patient experience will be key to strengthen the healthcare ecosystem.